Table 1 The identification of m5C sites in all 38 samples.

From: Transcriptome-wide RNA 5-methylcytosine profiles of human iPSCs and iPSC-derived cardiomyocytes

Reads mapped to:

Human reference genome Hg38

Spike-in control: Unmethylated firefly-luciferase mRNA

Sequenced sample libraries

Pooled Filtered reads

Mapped reads

% reads mapped /filtered

#m5C; mcov = 10 mr0.05 FDR = 0.05

C- > T conversion rate

Mapped Reads

% reads mapped /filtered

#m5C; mcov = 10 mr = 0.05 FDR = 0.01

C- > T conversion rate

hiPSCs(1103)-1

22,074,598

17,704,062

80.20%

51,329

0.9987

1,367

0.01%

0

0.9987

hiPSCs(1103)-2

17,034,687

13,339,820

78.31%

44,401

0.9989

850

0.00%

0

0.9986

hiPSCs(1103)-3

16,850,669

13,031,555

77.34%

38,985

0.9991

1,073

0.01%

3

0.9989

hiPSC(1103)-CM-1

17,400,153

13,492,390

77.54%

64,260

0.9988

2,021

0.01%

17

0.9969

hiPSC(1103)-CM-2

34,755,661

25,044,988

72.06%

89,574

0.9988

13,905

0.04%

0

0.9986

hiPSC(1103)-CM-3

9,004,846

6,259,766

69.52%

35,157

0.9981

3,120

0.03%

2

0.9988

hiPSCs(1103)-CM-lac-1

39,186,930

31,443,665

80.24%

86,454

0.9987

4,014

0.010%

6

0.9984

hiPSCs(1103)-CM-lac-2

41,428,004

33,076,311

79.84%

118,053

0.9976

3,928

0.009%

3

0.9983

hiPSCs(1103)-CM-lac-3

47,536,604

37,793,708

79.50%

118,414

0.9983

4,254

0.009%

2

0.9982

hiPSCs(1103)-CM-TDI-1

44,057,030

36,074,397

81.88%

109,258

0.9985

2,750

0.006%

1

0.9986

hiPSCs(1103)-CM-TDI-2

46,927,187

38,099,690

81.19%

111,406

0.9985

3,074

0.007%

1

0.9988

hiPSCs(1103)-CM-TDI-3

42,097,493

33,361,703

79.25%

107,583

0.9982

3,840

0.009%

9

0.998

hAFSC-iPSC-1

58,925,084

43,048,724

73.06%

50,259

0.9992

2,604

0.00%

3

0.9988

hAFSC-iPSC-2

19,915,577

14,043,081

70.51%

51,566

0.9986

1,630,158

8.19%

23

0.9986

hAFSC-iPSC-3

54,956,886

41,816,608

76.09%

117,759

0.9984

3,223

0.01%

2

0.9989

hAFSC-iPSC-4

46,871,023

34,968,133

74.61%

120,350

0.9988

2,893

0.01%

12

0.9966

hAFSC-iPSC-CM-1

53,679,189

37,031,345

68.99%

76,453

0.989

2,702

0.01%

1

0.9987

hAFSC-iPSC-CM-2

37,217,977

27,178,049

73.02%

98,359

0.9992

3,498

0.01%

2

0.9979

hAFSC-iPSC-CM-3

41,695,404

27,531,206

66.03%

179,246

0.9987

3,332

0.01%

1

0.9988

hAFSC-iPSC-CM-lac-1

40,589,291

30,804,171

75.89%

99,608

0.998

1,908

0.005%

2

0.9988

hAFSC-iPSC-CM-lac-2

41,160,545

31,899,272

77.50%

110,118

0.9978

1,700

0.004%

2

0.9984

hAFSC-iPSC-CM-lac-3

45,481,881

34,872,648

76.67%

98,658

0.998

1,820

0.004%

2

0.9984

hAFSC-iPSC-CM-TDI-1

42,788,928

32,733,167

76.50%

93,232

0.9983

1,800

0.004%

4

0.9984

hAFSC-iPSC-CM-TDI-2

37,416,855

28,696,409

76.69%

88,459

0.9982

1,762

0.005%

2

0.998

hAFSC-iPSC-CM-TDI-3

32,172,657

24,567,063

76.36%

86,031

0.9979

1,226

0.004%

3

0.9989

hESC(RUES2)-1

55,636,450

40,518,423

72.83%

56,766

0.9991

2,013

0.00%

1

0.9987

hESC(RUES2)-2

17,624,476

12,754,417

72.37%

51,950

0.9988

1,452,791

8.24%

2

0.9986

hESC(RUES2)-3

46,009,412

34,978,457

76.02%

270,190

0.9964

1,656

0.00%

1

0.999

hESC(RUES2)-4

49,007,850

36,482,544

74.44%

107,529

0.9987

2,140

0.00%

1

0.9992

hESC-CM(RUES2-CM)-1

54,823,858

39,558,387

72.16%

56,971

0.9991

2,208

0.00%

0

0.999

hESC-CM(RUES2-CM)-2

20,146,987

14,896,408

73.94%

28,886

0.9994

680

0.00%

3

0.9985

hESC-CM(RUES2-CM)-3

35,517,244

26,964,049

75.92%

59,842

0.9994

950

0.00%

2

0.9991

hESC(RUES2)-CM-lac -1

52,093,456

40,635,437

78.00%

164,763

0.9978

2,708

0.005%

4

0.9978

hESC(RUES2)-CM-lac -2

51,582,269

39,601,331

76.77%

163,947

0.9979

3,442

0.007%

8

0.9982

hESC(RUES2)-CM-lac -3

52,628,240

40,606,338

77.16%

183,351

0.9973

2,594

0.005%

5

0.9988

hESC(RUES2)-CM-TDI -1

40,932,345

32,232,377

78.75%

127,776

0.9976

2,152

0.005%

2

0.9988

hESC(RUES2)-CM-TDI -2

38,049,403

30,194,759

79.36%

99,369

0.9983

2,596

0.007%

4

0.9984

hESC(RUES2)-CM-TDI -3

39,945,971

31,330,641

78.43%

113,880

0.9979

1,980

0.005%

6

0.9977

  1. Table 1. BT-mRNA seq libraries were mapped to the in silico-converted reference genome and sequence. #m5C identification includes three criteria: (1) minimum coverage of 10 reads, (2) minimum methylation ratio 0.05, and (3) false discovery rate of 0.05 in reference genome or 0.01 in spike-in sequence.